| __timestamp | Agios Pharmaceuticals, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 1488000000 |
| Thursday, January 1, 2015 | 141827000 | 1525000000 |
| Friday, January 1, 2016 | 220163000 | 2111000000 |
| Sunday, January 1, 2017 | 292681000 | 1848000000 |
| Monday, January 1, 2018 | 341324000 | 1213000000 |
| Tuesday, January 1, 2019 | 410894000 | 1010000000 |
| Wednesday, January 1, 2020 | 367470000 | 997000000 |
| Friday, January 1, 2021 | 256973000 | 967000000 |
| Saturday, January 1, 2022 | 279910000 | 838000000 |
| Sunday, January 1, 2023 | 288903000 | 953000000 |
| Monday, January 1, 2024 | 301286000 | 998000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical landscape, research and development (R&D) are pivotal for innovation and growth. Over the past decade, Teva Pharmaceutical Industries Limited and Agios Pharmaceuticals, Inc. have demonstrated contrasting R&D investment strategies.
Teva, a global leader in generic and specialty medicines, has consistently allocated substantial resources to R&D, peaking in 2016 with a 63% increase from 2014. However, by 2023, their R&D spending had decreased by 36% from its peak, reflecting strategic shifts or market pressures.
Conversely, Agios, a biopharmaceutical company focused on cellular metabolism, showed a steady increase in R&D investment, with a notable 188% rise from 2014 to 2019. Despite a slight dip in 2020, Agios maintained a robust R&D budget, underscoring its commitment to innovation.
These trends highlight the dynamic nature of R&D investments and their critical role in shaping the future of pharmaceutical companies.
Novo Nordisk A/S or Teva Pharmaceutical Industries Limited: Who Invests More in Innovation?
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and Axsome Therapeutics, Inc.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Corcept Therapeutics Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Viking Therapeutics, Inc.
R&D Insights: How Teva Pharmaceutical Industries Limited and Protagonist Therapeutics, Inc. Allocate Funds
Teva Pharmaceutical Industries Limited vs Novavax, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Ascendis Pharma A/S and Agios Pharmaceuticals, Inc.
Analyzing R&D Budgets: Grifols, S.A. vs Agios Pharmaceuticals, Inc.
Analyzing R&D Budgets: Corcept Therapeutics Incorporated vs Agios Pharmaceuticals, Inc.
Analyzing R&D Budgets: Viking Therapeutics, Inc. vs Agios Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Agios Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Comparing Innovation Spending: Agios Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.